Brought to you by 
CryoCath nets $12.5mm with FOPO
08 Oct 2002
Executive Summary
CryoCath Technologies Inc. (cryotherapy products to treat cardiovascular disease) netted $12.5mm ($Cdn19.5mm) through a follow-on public offering of 2.9mm units at $4.50 apiece, including the overallotment. Each unit consists of one common share and one-half of a one-year common share purchase warrant; each full warrant permits the purchase of an additional common share for $5.77.
Deal Industry
- Medical Devices
-
Medical Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
-
Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Financing
- FOPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
CryoCath nets $12.5mm with FOPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice